WallStSmart

Seritage Growth Properties (SRG)vsWelltower Inc (WELL)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 110070% more annual revenue ($13.79B vs $12.52M). WELL leads profitability with a 12.1% profit margin vs 0.0%. WELL earns a higher WallStSmart Score of 53/100 (C-).

SRG

Avoid

26

out of 100

Grade: F

Growth: 2.0Profit: 2.5Value: 5.0Quality: 7.5
Piotroski: 6/9Altman Z: -0.63

WELL

Buy

53

out of 100

Grade: C-

Growth: 10.0Profit: 5.0Value: 2.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for SRG.

WELLSignificantly Overvalued (-80.5%)

Margin of Safety

-80.5%

Fair Value

$135.40

Current Price

$244.67

$109.27 premium

UndervaluedFair: $135.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

SRG2 strengths · Avg: 9.5/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.179/10

Conservative balance sheet, low leverage

WELL3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
38.4%10/10

Revenue surging 38.4% year-over-year

Market CapQuality
$179.68B9/10

Large-cap with strong market position

EPS GrowthGrowth
30.3%8/10

Earnings expanding 30.3% YoY

Areas to Watch

SRG4 concerns · Avg: 2.5/10
Market CapQuality
$85.61M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-25.9%2/10

ROE of -25.9% — below average capital efficiency

Revenue GrowthGrowth
-56.0%2/10

Revenue declined 56.0%

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.0%3/10

ROE of 3.0% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
103.8x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : SRG

The strongest argument for SRG centers on Price/Book, Debt/Equity.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 38.4% demonstrates continued momentum.

Bear Case : SRG

The primary concerns for SRG are Market Cap, Profit Margin, Return on Equity.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 103.8x leaves little room for execution misses.

Key Dynamics to Monitor

SRG profiles as a value stock while WELL is a growth play — different risk/reward profiles.

SRG carries more volatility with a beta of 2.27 — expect wider price swings.

WELL is growing revenue faster at 38.4% — sustainability is the question.

WELL generates stronger free cash flow (449M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (53/100 vs 26/100) and 38.4% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Seritage Growth Properties

REAL ESTATE · REAL ESTATE SERVICES · USA

Seritage Growth Properties is a publicly traded, self-managed and self-managed REIT with 166 wholly owned properties and 29 unconsolidated properties totaling approximately 30.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?